Overview
- 161 inspections across 152 sites are on record.
- 321 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-07.
At a glance
Inspections
161
Sites
152
Observations
321
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Turbare Manufacturing | 7 May 2026 | Human Drugs | On file |
| Revive Rx LLC dba Revive Rx Pharmacy | 27 Mar 2026 | Human Drugs | On file |
| Pyramid Laboratories, Inc. | 13 Feb 2026 | Human Drugs | On file |
| Centaur Pharmaceuticals Private Limited | 14 Nov 2025 | Human Drugs | |
| Marksans Pharma Limited | 7 Nov 2025 | Human Drugs |
Sites inspected
Turbare ManufacturingConway, United States1 insp.
Revive Rx LLC dba Revive Rx PharmacyHouston, United States1 insp.
Pyramid Laboratories, Inc.Costa Mesa, United States1 insp.
Centaur Pharmaceuticals Private LimitedPernem, India1 insp.
Marksans Pharma LimitedVerna, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Heika R Tait9 shared
Joan M Cantellops Figueroa5 shared
Kenneth O Gee4 shared
Carolina D Vasquez3 shared
Deyaa Shaheen3 shared
Dongping Dai3 shared
Steven P Donald3 shared
Miguel A Martinez3 shared
Bryan A Galvez2 shared
Monica E Murie2 shared
Full investigator report
Get the verbatim findings behind Sangeeta M Khurana's 321 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site